ArticleFrontiers in bioengineering and biotechnology2025
Awareness of the dual-use dilemma in scientific research: reflections and challenges to Latin America.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Without safeguards, AI-Biology integration risks accelerating future pandemics.Frontiers in microbiology · 2025Article
- AI-powered analysis of viral metagenomic sequencing data for rapid outbreak investigation and novel pathogen discovery.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The dual-use dilemma compels us to reflect on scientific responsibility, ethical regulation, and the role of society in the governance of knowledge. While science has the potential to transform the world for the better, it can also become a double-edged sword if the implications of its potential misuse are overlooked. This is particularly relevant in the life sciences, where advances can be repurposed for harmful by secondary actors. Addressing this challenge requires the development of preventive tools, biosafety and biosecurity measures specifically designed for dual-use research, and clear, up-to-date regulatory frameworks at both national and international levels. These mechanisms should aim to anticipate risks, restrict unauthorized access to sensitive information, and foster a culture of responsibility within the scientific community, without hindering the advancement of knowledge or obstructing legitimate innovation. This perspective explores the dual-use dilemma through a global lens, with a specific focus on Latin America, a region where policies and institutional awareness on dual-use risks remain limited. By analyzing illustrative case studies, existing international tools, and regional gaps, this work highlights both the obstacles and opportunities for strengthening dual-use governance in Latin American research systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.